MacuMira
A New Advanced Treatment for Dry AMD
| MacuMira is Canada’s first clinically proven treatment for dry age-related macular degeneration, whose goal is to improve function of the photoreceptor cells in your macula (the center of the retina). This is performed by delivering energy to the retinal cells. The category of treatment is PHOTO-BIOMODULATION. Health Canada has approved the Macumira treatment protocol of safe, low level microcurrent technology. There is a similar Photo-Biomodulation treatment that was FDA approved in the United States using light. |
What is the goal?
The goal of treatment is to stimulate the retina cells with energy. This is a longterm goal.
You may see improvement in vision and/or contrast sensitivity.
You can expect three outcomes: